PETU: Positron Emission Tomography of Infection and Vasculitis

Sponsor
Turku University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01878721
Collaborator
(none)
117
1
129
0.9

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the value of positron emission tomography/computed tomography in various inflammatory conditions caused by bacterial infection or vasculitis. Glucose analog FDG is sensitive to detect inflammation foci but we hypothesize that other imaging agents such as PK11195 and Ga-citrate may have added value in certain applications.

Condition or Disease Intervention/Treatment Phase
  • Radiation: PET/CT

Detailed Description

The purpose of this study is to evaluate the value of PET/CT in various inflammatory conditions caused by bacterial infection or vasculitis. Our aim is to:

  1. investigate whether FDG (18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose) PET/CT and 68Ga-(Gallium-68) citrate PET/CT enable the early and accurate detection of metastatic infection foci in Staphylococcus aureus bacteremia.

  2. study the usefulness of FDG PET/CT in detection of endovascular infection in bacteremia caused by Salmonella spp.

  3. find an optimal FDG PET/CT protocol for detection of infectious endocarditis and metastatic infection foci related to endocarditis.

  4. study the value of FDG PET/CT in the diagnosis of infection of pacemaker or implantable cardioverter defibrillator.

  5. investigate the usefulness of FDG PET/CT, 68Ga-citrate PET/CT, and 11C- (carbon-11) translocator protein ligand (PK11195) PET/CT in diagnosis of vasculitis and in imaging of the magnitude of the vascular changes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
117 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Positron Emission Tomography of Infection and Vasculitis (PETU)
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Oct 1, 2021
Actual Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Staphylococcus aureus bacteremia

PET/CT in patients with Staphylococcus aureus bacteremia

Radiation: PET/CT
positron emission tomography/computed tomography

Salmonella spp. bacteremia

PET/CT in patients with Salmonella spp. bacteremia

Radiation: PET/CT
positron emission tomography/computed tomography

Endocarditis

PET/CT in patients with infective endocarditis

Radiation: PET/CT
positron emission tomography/computed tomography

Pacemaker infection

PET/CT in patients with pacemaker infection

Radiation: PET/CT
positron emission tomography/computed tomography

Vasculitis

PET/CT in patients with vasculitis

Radiation: PET/CT
positron emission tomography/computed tomography

Outcome Measures

Primary Outcome Measures

  1. Detection of infection or vasculitis in PET images [within 1 week after starting the treatment]

Secondary Outcome Measures

  1. Standardized uptake value of PET imaging agent at the site of infection or vasculitis [within 1 week after starting the treatment]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Adults with

  • Staphylococcus aureus bacteremia or

  • Salmonella spp. bacteremia or

  • infective endocarditis or

  • infection of pacemaker or implantable cardioverter defibrillator or

  • vasculitis

Exclusion Criteria:
  • underage, pregnant, breastfeeding, handicapped or prisoner

Contacts and Locations

Locations

Site City State Country Postal Code
1 Turku University Hospital Turku Finland FI-20521

Sponsors and Collaborators

  • Turku University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anne Roivainen, professor, Turku University Hospital
ClinicalTrials.gov Identifier:
NCT01878721
Other Study ID Numbers:
  • 14824
First Posted:
Jun 17, 2013
Last Update Posted:
Oct 22, 2021
Last Verified:
Oct 1, 2021
Keywords provided by Anne Roivainen, professor, Turku University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2021